Unknown

Dataset Information

0

Boldine Attenuates Synaptic Failure and Mitochondrial Deregulation in Cellular Models of Alzheimer's Disease.


ABSTRACT: Alzheimer's disease (AD) is the most common cause of senile dementia worldwide, characterized by both cognitive and behavioral deficits. Amyloid beta peptide (A?) oligomers (A?O) have been found to be responsible for several pathological mechanisms during the development of AD, including altered cellular homeostasis and synaptic function, inevitably leading to cell death. Such A?O deleterious effects provide a way for identifying new molecules with potential anti-AD properties. Available treatments minimally improve AD symptoms and do not extensively target intracellular pathways affected by A?O. Naturally-derived compounds have been proposed as potential modifiers of A?-induced neurodysfunction and cytotoxicity based on their availability and chemical diversity. Thus, the aim of this study was to evaluate boldine, an alkaloid derived from the bark and leaves of the Chilean tree Peumus boldus, and its capacity to block some dysfunctional processes caused by A?O. We examined the protective effect of boldine (1-10 ?M) in primary hippocampal neurons and HT22 hippocampal-derived cell line treated with A?O (24-48 h). We found that boldine interacts with A? in silico affecting its aggregation and protecting hippocampal neurons from synaptic failure induced by A?O. Boldine also normalized changes in intracellular Ca2+ levels associated to mitochondria or endoplasmic reticulum in HT22 cells treated with A?O. In addition, boldine completely rescued the decrease in mitochondrial membrane potential (??m) and the increase in mitochondrial reactive oxygen species, and attenuated A?O-induced decrease in mitochondrial respiration in HT22 hippocampal cells. We conclude that boldine provides neuroprotection in AD models by both direct interactions with A? and by preventing oxidative stress and mitochondrial dysfunction. Additional studies are required to evaluate the effect of boldine on cognitive and behavioral deficits induced by A? in vivo.

SUBMITTER: Toledo JP 

PROVIDER: S-EPMC7933475 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Boldine Attenuates Synaptic Failure and Mitochondrial Deregulation in Cellular Models of Alzheimer's Disease.

Toledo Juan P JP   Fernández-Pérez Eduardo J EJ   Ferreira Ildete L IL   Marinho Daniela D   Riffo-Lepe Nicolas O NO   Pineda-Cuevas Benjamin N BN   Pinochet-Pino Luis F LF   Burgos Carlos F CF   Rego A Cristina AC   Aguayo Luis G LG  

Frontiers in neuroscience 20210219


Alzheimer's disease (AD) is the most common cause of senile dementia worldwide, characterized by both cognitive and behavioral deficits. Amyloid beta peptide (Aβ) oligomers (AβO) have been found to be responsible for several pathological mechanisms during the development of AD, including altered cellular homeostasis and synaptic function, inevitably leading to cell death. Such AβO deleterious effects provide a way for identifying new molecules with potential anti-AD properties. Available treatme  ...[more]

Similar Datasets

| S-EPMC5605817 | biostudies-other
| S-EPMC5771400 | biostudies-literature
| S-EPMC5494197 | biostudies-literature
| S-EPMC3478410 | biostudies-literature
| S-EPMC5561922 | biostudies-other
| S-EPMC9258209 | biostudies-literature
| S-EPMC5562654 | biostudies-other
| S-EPMC7036943 | biostudies-literature
| S-EPMC3307224 | biostudies-literature
| S-EPMC8299068 | biostudies-literature